SCHEMBL27168546

SCHEMBL27168546

O=[N+]([O-])c1cccc(C2=CCOCC2)c1CCO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.34
▸ TDP1 Q9NUW8 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ S100A4 P26447 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ GPR35 Q9HC97 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HNF4A P41235 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ PTPRC P08575 1/20 0.31
▸ PIK3CD O00329 2/20 0.31
▸ PIK3CA P42336 2/20 0.31
▸ PDCD1 Q15116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27168516 0.88 MAPK14 (0.34) MAPK14TDP1ALDH1A1S100A4KMT2A
SCHEMBL29516860 0.78 S100A4 (0.37) MAPK14TDP1ALDH1A1S100A4KMT2A
SCHEMBL25529496 0.78 S100A4 (0.37) MAPK14TDP1ALDH1A1S100A4KMT2A
SCHEMBL27168535 0.75 MAPK14 (0.34) MAPK14TDP1S100A4KMT2AMAPT
SCHEMBL26162618 0.75 MAPT (0.39) MAPK14ALDH1A1KMT2AMAPTRECQL
SCHEMBL7159890 0.73 GPR35 (0.54) TDP1ALDH1A1S100A4KMT2AGPR35
SCHEMBL26162646 0.72 MAPK14 (0.34) MAPK14TDP1ALDH1A1S100A4KMT2A
SCHEMBL26162637 0.72 MAPK14 (0.36) MAPK14TDP1ALDH1A1S100A4KMT2A
SCHEMBL25197753 0.72 IDH2 (0.36) MAPK14TDP1ALDH1A1RECQLPIK3CD
SCHEMBL29517002 0.72 IDH2 (0.36) MAPK14TDP1ALDH1A1RECQLPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421217-B2 Pyrazine derivative or salt thereof, and use of same FUJIFILM CORPORATION (JP) 2025-09-23 — — US disclosed
EP-4052760-B1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM CORP (JP) 2024-03-13 — — EP disclosed
EP-4052760-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM Corporation (JP) 2022-09-07 — — EP disclosed
US-20220259185-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME FUJIFILM CORPORATION (JP) 2022-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12421217-B2 Pyrazine derivative or salt thereof, and use of same DHODH, IDH1, IDH2 MAPK14 2456/4885TDP1 1422/4885ALDH1A1 117/4885
US-20220259185-A1 PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME DHODH, IDH1, IDH2 MAPK14 2456/4885TDP1 1422/4885ALDH1A1 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback